Matches in Wikidata for { <http://www.wikidata.org/entity/Q67129781> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q67129781 description "clinical trial" @default.
- Q67129781 description "ensayu clínicu" @default.
- Q67129781 description "klinisch onderzoek" @default.
- Q67129781 description "клінічне випробування" @default.
- Q67129781 name "Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Adults With Chronic HCV and HBV Coinfection" @default.
- Q67129781 name "Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Adults With Chronic HCV and HBV Coinfection" @default.
- Q67129781 type Item @default.
- Q67129781 label "Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Adults With Chronic HCV and HBV Coinfection" @default.
- Q67129781 label "Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Adults With Chronic HCV and HBV Coinfection" @default.
- Q67129781 prefLabel "Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Adults With Chronic HCV and HBV Coinfection" @default.
- Q67129781 prefLabel "Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Adults With Chronic HCV and HBV Coinfection" @default.
- Q67129781 P1050 Q67129781-39D8D817-2BD9-405C-8C44-0BB9A58FDA1F @default.
- Q67129781 P1050 Q67129781-9CDEB9C4-A73B-4022-AD13-0B0C996BCE02 @default.
- Q67129781 P1050 Q67129781-C9400E2E-F04F-428C-95FA-E27263C274FA @default.
- Q67129781 P1132 Q67129781-4202C5C2-864E-4130-9B52-55146F922C2E @default.
- Q67129781 P1476 Q67129781-28C4B135-A9ED-4BEA-BCF6-CE3F51578AAB @default.
- Q67129781 P17 Q67129781-40A4B01D-C35D-4C6B-BFD9-E3354804947E @default.
- Q67129781 P2899 Q67129781-769C229B-F2BF-41FE-A4DA-7DF466254102 @default.
- Q67129781 P3098 Q67129781-F80E2245-9592-46B3-8FFC-42ABBE66BE54 @default.
- Q67129781 P31 Q67129781-7321D52A-6829-4B0A-9303-FF4E584C035B @default.
- Q67129781 P4844 Q67129781-AEB023BC-4BAB-40D5-88CF-79140B738DB6 @default.
- Q67129781 P580 Q67129781-1BC87D9B-0605-4E03-883F-CABC5DAD20E6 @default.
- Q67129781 P582 Q67129781-E5DC20D4-26DF-45D2-BA3B-6DA25011C8EA @default.
- Q67129781 P6099 Q67129781-AF7651F8-E5C9-46E9-9F55-F23E276EA6BF @default.
- Q67129781 P8363 Q67129781-0C938A64-15D0-4489-9453-B705A41E1730 @default.
- Q67129781 P1050 Q131742 @default.
- Q67129781 P1050 Q154869 @default.
- Q67129781 P1050 Q157661 @default.
- Q67129781 P1132 "+111" @default.
- Q67129781 P1476 "A Phase 3b Open-Label Study of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 or 2 Hepatitis C Virus (HCV) and Hepatitis B Virus (HBV) Coinfection" @default.
- Q67129781 P17 Q865 @default.
- Q67129781 P2899 "+20" @default.
- Q67129781 P3098 "NCT02613871" @default.
- Q67129781 P31 Q30612 @default.
- Q67129781 P4844 Q2502747 @default.
- Q67129781 P580 "2015-12-21T00:00:00Z" @default.
- Q67129781 P582 "2017-01-04T00:00:00Z" @default.
- Q67129781 P6099 Q42824827 @default.
- Q67129781 P8363 Q78089383 @default.